Joanne Wing Yan Chiu

7PUBLICATIONS
37CO-AUTHORS
Molecular targetsForensic epidemiologyDisease surveillancePredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 12, 2024
Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.

Loren Michel, Antonio Jimeno, Ammar Sukari

|Jun 02, 2024
Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trial.

Javier Cortés, Sara A Hurvitz, Seock-Ah Im

|Aug 08, 2023
Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel.

Joanne Wing Yan Chiu, Soo Chin Lee, James Chung-Man Ho

|Jul 10, 2023
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.

Martin Gutierrez, Wei-Sen Lam, Matthew D Hellmann

|Apr 17, 2023
Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.

Chi Yan Wong, Roland Leung, Gin Wai Kwok

|Oct 26, 2021
Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers.

Bryan Li, Thomas Yau, Roland Leung

Pageof 2

Frequent Collaborators

2 joint publications

Sherene Loi

1 joint publications

Chi Yan Wong

1 joint publications

Loren Michel

1 joint publications

Antonio Jimeno